In early 2026, Roche paid $100 million to secure a non-exclusive patent licence from Structures subsidiary Gasherbrum Bio, covering intellectual property relevant to CT-996, the oral GLP-1 compound Roche acquired through its $2.7 billion buyout of Carmot Therapeutics in late 2023
You May Be More Prone to Certain GLP-1 Side Effects Some medications used in the treatment of bipolar, such as olanzapine (Zyprexa), can slow your gut and stop you up, says McIntyre
This approach delivers hydration, electrolytes, and essential vitamins directly into your bloodstream, often providing quick relief from symptoms
The thyroid GLP-1 connection- how much does increasing detection and ascertainment bias contribute to possible associations with GLP-1 medicines
2 Treatment Unfortunately, the biggest concern with current therapy is that there are no efficacious treatments for slowing or halting disease progression
By calming this chronic inflammation, GLP-1s can support better insulin sensitivity, hormone balance, and overall metabolic health